Zobrazeno 1 - 10
of 529
pro vyhledávání: '"H Pelzer"'
Publikováno v:
European Journal of Haematology. 47:55-59
Cytostatic therapy is known to aggravate tumor-induced coagulopathy. Therefore, we have studied the effect of different chemotherapeutic regimens on the activation of coagulation and fibrinolysis in patients with non-Hodgkin's lymphomas or acute leuk
Autor:
Marion Kläser, H. Claus, Peter Schweiss, T. Zenner, German Müller-Vogt, H. Pelzer, H. Wühl, J. Büttner, T. Wolf, B. Obst
Publikováno v:
Journal of Low Temperature Physics. 105:909-914
Measurements of the anisotropic electrical resistivity, the Hall Effect, and the specific heat anomaly at Tc of Ca-doped YBa2Cu3Ox single crystals of various Ca and O contents are presented. The transport properties are discussed in terms of charge a
Publikováno v:
Clinical Child Psychology and Psychiatry, 1, 251-263. SAGE Publications Inc.
The development of the child's `theory of mind' is the subject of considerable research interest. An important part of this work is concerned with children's understanding of mental states and recognition of emotions. Both areas are relevant to how c
Publikováno v:
Hämostaseologie. 14:37-43
ZusammenfassungHeparin hat einen signifikanten Einfluß auf eine ganze Reihe von Laboruntersuchungen in der Hämostase. Häufig gelingt daher unter Heparintherapie nicht mehr der Nachweis von bestimmten Gerinnungsstörungen, deren Kenntnis jedoch fü
Autor:
R. Bader, E. M. Solleder, L. M. Teijidor, Armando Tripodi, I. Ramirez, H.-J. Kolde, P. M. Mannucci, H. Pelzer, Jack Hirsh, F. Keller, P. Hawkins, M. Peng
Publikováno v:
Thrombosis and Haemostasis. 71:292-299
SummaryA new PT reagent based on recombinant human tissue factor and synthetic phospholipids (phosphatidyl choline and phosphatidyl serine) with defined fatty acid side chains was calibrated against BCT/253 and CRM 149R. A small but consistent bias i
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia. 18(1)
N8 is a new recombinant factor VIII (rFVIII) compound produced and formulated without human- or animal-derived protein. The aims of the present studies were to evaluate the pharmacokinetics and pharmacodynamics properties of N8 and to compare with a
Autor:
D F, Brophy, E J, Martin, J, Christian Barrett, M E, Nolte, J G, Kuhn, P M, Gerk, M E, Carr, H, Pelzer, H, Agersø, M, Ezban, U, Hedner
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia. 17(5)
Recombinant FVIIa is a haemostatic agent administered to patients with severe FVIII or FIX deficiency with inhibitors. Although rFVIIa is effective at stopping bleeding, a reliable assay to monitor its effect is lacking. To characterize the pharmacok
Publikováno v:
Fibrinolysis. 7:69-74
A novel enzyme-linked immunosorbent assay (ELISA) for quantification of α2-antiplasmin-plasmin complex (APP) in undiluted plasma was developed. The assay follows the sandwich principle and uses two different antibodies directed against plasmin-modif
Publikováno v:
Fibrinolysis. 7:109-115
Previous studies showed an early increase of fibrinopeptide A and thrombin-anti-thrombin III complex (TAT) plasma levels during thrombolytic therapy. This might be caused not only by liberation of preformed thrombin from the thrombus or reperfused ti